The US Food and Drug Administration (FDA) has approved a new drug for treating adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a confirmed FLT3 mutation.
from Medindia Health News https://ift.tt/2TZO6aE
No comments:
Post a Comment